EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reported Early Clinical Outcomes of Forward-Planned Multileaf Collimator-Based 3-Dimensional Conformal Spatially Fractionated Radiation Therapy Technique for Large and Bulky Tumors

James A Knight, Nick Trosper, Josh Misa, Mark E Bernard, Denise Fabian, Mahesh Kudrimoti, Weisi Yan, William St Clair, Eddy S Yang, Damodar Pokhrel

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.04.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von James A Knight und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, 40536 USA. Hauptthemen laut MEDLINE: Radiotherapy, Conformal, Radiotherapy Planning, Computer-Assisted, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Conventionally fractionated radiation therapy for large, bulky (≥8 cm), unresectable tumors has been hampered by radiation-induced morbidity, but application of spatially fractionated radiation therapy (SFRT) for both palliative and curative intent has been increasingly accepted. We report our clinical use of novel 3-dimensional conformal multileaf collimator (MLC)-based SFRT with same-day computed tomography simulation and forward-planning method, providing a safe, rapidly efficacious reduction in disease burden and pain, with minimal normal-tissue toxicity. METHODS AND MATERIALS: Patients with large, unresectable bulky tumors received 15 Gy in 1 fraction to the gross tumor volume (GTV) within an hour of computed tomography simulation, using a forward-planned MLC-based SFRT technique. All patients subsequently received either 30 Gy in 10 fractions, generally 2 days after SFRT for palliative intent, or site-specific, full-prescription doses starting 2 to 3 days after SFRT for curative intent. Patients underwent follow-up examinations and imaging in 3-month intervals to assess tumor response, pain control, and radiation-associated toxicity. RESULTS: Between November 2019 and January 2024, 24 large tumors in 23 patients were analyzed. Median follow-up was 6 months (range 3-36 months). After SFRT, 16 patients (69.5%) proceeded with palliative-intent radiation therapy, 6 patients (26.0%) underwent curative-intent radiation therapy, and 1 patient (4.3%) declined further radiation therapy. Seven patients (30.4%) reported acute radiation-associated toxicities. A total of 3 acute grade ≥3 toxicities (13.0%) were reported, but no grade 5 toxicities occurred. Complete or partial response was seen in 14 of 24 (58%) tumors; clinical benefit rate was 79.2%. Twenty of 23 patients (86.9%) reported pain relief from tumor burden. CONCLUSIONS: Same-day 3-dimensional MLC-based SFRT method provides fast, safe, and effective management of large, bulky, unresectable tumors for both palliative and therapeutic intents across a wide range of tumor sites and histologies, reducing tumor burden and improving patient comfort and compliance. This method could be useful for rapid SFRT including adaptive treatment. We recommend commissioning and validating this method at other institutions, including community cancer centers, to expand the access of efficient, high-quality SFRT treatment to underserved patient cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, ConformalRadiotherapy Planning, Computer-AssistedNeoplasmsHumansDose Fractionation, RadiationMaleMiddle AgedAgedFemaleTumor BurdenTreatment OutcomePalliative CareTomography, X-Ray ComputedAdultAged, 80 and overOrgans at Risk

Autor:innen und Institutionen

  • Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, 40536 USA.
  • Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, 40536 USA. Electronic address: damodar.pokhrel@uky.edu.

Zitieren

APA

Knight, J. A., Trosper, N., Misa, J., Bernard, M. E., Fabian, D., Kudrimoti, M., Yan, W., St Clair, W., Yang, E. S., & Pokhrel, D. (2025). Reported Early Clinical Outcomes of Forward-Planned Multileaf Collimator-Based 3-Dimensional Conformal Spatially Fractionated Radiation Therapy Technique for Large and Bulky Tumors. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.04.016

Vancouver

Knight JA, Trosper N, Misa J, Bernard ME, Fabian D, Kudrimoti M, et al. Reported Early Clinical Outcomes of Forward-Planned Multileaf Collimator-Based 3-Dimensional Conformal Spatially Fractionated Radiation Therapy Technique for Large and Bulky Tumors. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.04.016

BibTeX
@article{Knight2025,
  author = {Knight, James A and Trosper, Nick and Misa, Josh and Bernard, Mark E and Fabian, Denise and Kudrimoti, Mahesh and Yan, Weisi and St Clair, William and Yang, Eddy S and Pokhrel, Damodar},
  title = {Reported Early Clinical Outcomes of Forward-Planned Multileaf Collimator-Based 3-Dimensional Conformal Spatially Fractionated Radiation Therapy Technique for Large and Bulky Tumors},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.04.016}
}
Kostenlos starten →